HOWL

Werewolf Therapeutics, Inc.

2.98 USD
+0.09 (+3.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Werewolf Therapeutics, Inc. stock is down -37.66% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May. 100% of analysts rate it a buy.

About Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies.

  • JP Morgan
    Tue Jun 4, 08:21
    buy
    confirm
  • HC Wainwright & Co.
    Mon Jun 3, 10:12
    buy
    confirm
  • HC Wainwright & Co.
    Fri May 24, 06:51
    buy
    confirm